Remove category special-report
article thumbnail

Merck announces Remarkable Merck Young Scientists Awards 2023

Express Pharma

Held at Bangalore, the annual awards recognise the work of young scientists who are driving positive change in the lives of millions across India through their cutting-edge research in life sciences.

86
article thumbnail

Informa Connect’s Life Sciences Pricing & Contracting USA

Drug Channels

Discuss the nuances of reporting and laws for key Medicaid and GP programs with Genmab and Miree Lee Consulting. Hyman, Phelps & McNamara review the enforcement and penalties landscape within state drug pricing reporting. Cannot be combined with special category rates or other offers. Other restrictions may apply.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

CADTH advisory panel consults on framework for pan-Canadian formulary

Pharma in Brief

The feedback will inform a stakeholder session in spring 2022 and the Panel’s final report. As we previously reported , CADTH convened the Panel to: recommend principles and a framework for developing a pan-Canadian prescription drug list ( i. Final Report of the Advisory Council on the Implementation of National Pharmacare.

article thumbnail

PMPRB issues excessive price order on rare disease drug

Pharma in Brief

As we reported , the PMPRB is now applying an interim guidance based on the previous Guidelines , pending consultation on a new set of Guidelines. Cystagon has never been approved in Canada, but had been available since 1994 through the Special Access Programme ( SAP ). The Board rejected the proposed new category.

52
article thumbnail

Digital health financing bonanza slows in Q1

pharmaphorum

“It’s worth noting that Q1 isn’t usually a blockbuster period for funding,” said Rock Health analysts Adriana Krasniansky and Pavan Shah in the report, adding that this is further evidence that their may be seasonality in digital health funding. That’s a lot, but is still a sizeable drop on the $6.7

104
104
article thumbnail

Digital health firm Akili raises $163m in Nasdaq listing

pharmaphorum

Now that the merger with special purpose acquisition company (SPAC) Social Capital Suvretta Holdings Corp I has closed, the company’s principle Chamath Palihapitiya – a former Facebook executive and founder and CEO of investment group Social Capital – will come on board as Akili’s chair. .”

59
article thumbnail

Pear extends digital therapeutics partnership with Spero

pharmaphorum

We believe having access to patient-reported data via Pear’s clinician dashboard gives us better insight into patient behaviours.”. The extended agreement comes shortly after Pear reported a 24% quarter-over-quarter increase in revenues to $4.1